ANAPLASTIC LYMPHOMA KINASE
Clinical trials for ANAPLASTIC LYMPHOMA KINASE explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC LYMPHOMA KINASE trials appear
Sign up with your email to follow new studies for ANAPLASTIC LYMPHOMA KINASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to beat tough lymphoma
Disease control Recruiting nowThis early-phase study tests a combination of two drugs, alectinib and duvelisib, in 30 people with a rare type of blood cancer called ALK-positive anaplastic large cell lymphoma that has come back or not responded to prior treatment. The goal is to find a safe dose and see if th…
Matched conditions: ANAPLASTIC LYMPHOMA KINASE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Lung cancer drug brigatinib under Real-World watch in south korea
Disease control Recruiting nowThis study is monitoring the safety and effectiveness of the drug brigatinib in adults with a specific type of advanced lung cancer (ALK-positive NSCLC) in South Korea. Researchers will track side effects and how well the drug controls the cancer in 257 patients who are starting …
Matched conditions: ANAPLASTIC LYMPHOMA KINASE
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC